232 related articles for article (PubMed ID: 17304532)
1. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches.
Suba EJ; Donnelly AD; Furia LM; Huynh ML; Raab SS;
Diagn Cytopathol; 2007 Mar; 35(3):187-91. PubMed ID: 17304532
[TBL] [Abstract][Full Text] [Related]
2. Papanicolaou screening in developing countries: an idea whose time has come.
Suba EJ; Raab SS;
Am J Clin Pathol; 2004 Mar; 121(3):315-20. PubMed ID: 15023034
[TBL] [Abstract][Full Text] [Related]
3. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam.
Suba EJ; Nguyen CH; Nguyen BD; Raab SS;
Cancer; 2001 Mar; 91(5):928-39. PubMed ID: 11251944
[TBL] [Abstract][Full Text] [Related]
4. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
[TBL] [Abstract][Full Text] [Related]
5. Downstaging of cervical cancer.
Ananth R
J Indian Med Assoc; 2000 Feb; 98(2):41-4. PubMed ID: 11016148
[TBL] [Abstract][Full Text] [Related]
6. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis.
Ginsberg GM; Edejer TT; Lauer JA; Sepulveda C
Vaccine; 2009 Oct; 27(43):6060-79. PubMed ID: 19647813
[TBL] [Abstract][Full Text] [Related]
7. [Cervical cancer screening and associated treatment costs in France].
Bergeron C; Breugelmans JG; Bouée S; Lorans C; Bénard S; Rémy V
Gynecol Obstet Fertil; 2006 Nov; 34(11):1036-42. PubMed ID: 17070085
[TBL] [Abstract][Full Text] [Related]
8. Effective screening programmes for cervical cancer in low- and middle-income developing countries.
Sankaranarayanan R; Budukh AM; Rajkumar R
Bull World Health Organ; 2001; 79(10):954-62. PubMed ID: 11693978
[TBL] [Abstract][Full Text] [Related]
9. Crossing the quality chasm: a requirement for successful cervical cancer prevention in developing countries.
Suba EJ
Clin Lab Med; 2004 Dec; 24(4):945-63. PubMed ID: 15555750
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
11. [Cost effectiveness of human papilloma virus testing in cervical cancer screening: a literature review].
Mejía A; Salas W
Biomedica; 2008 Mar; 28(1):160-72. PubMed ID: 18645671
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer control in developing countries: memorandum from a WHO meeting.
Bull World Health Organ; 1996; 74(4):345-51. PubMed ID: 8823955
[TBL] [Abstract][Full Text] [Related]
13. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
14. Integrating human papillomavirus vaccination in cervical cancer control programmes.
Franco EL; Coutlée F; Ferenczy A
Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
[TBL] [Abstract][Full Text] [Related]
15. [Cost effectiveness of cervical cancer screening strategies in Tunisia].
Hsaïri M; Fakhfakh R; Ghyoula M; Ben Abdallah M; Achour N
Tunis Med; 2000 Oct; 78(10):557-61. PubMed ID: 11190738
[TBL] [Abstract][Full Text] [Related]
16. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
17. Cervical cancer prevention for all the world's women: new approaches offer opportunities and promise.
Wright TC; Blumenthal P; Bradley J; Denny L; Esmy PO; Jayant K; Nene BM; Pollack AE; Rajkumar R; Sankaranarayanan R; Sellors JW; Shastri SS; Sherris J; Tsu V
Diagn Cytopathol; 2007 Dec; 35(12):845-8. PubMed ID: 18008343
[No Abstract] [Full Text] [Related]
18. Mobilization for cervical cancer screening: lessons from a poor-urban Yoruba community in Nigeria.
Thomas JO; Babarinsa IA; Ajayi IO; Fawole O; Ojemakinde KO; Omigbodun AO
Afr J Med Med Sci; 2005 Mar; 34(1):81-5. PubMed ID: 15973782
[TBL] [Abstract][Full Text] [Related]
19. Making the case for cervical cancer prevention: what about equity?
Tsu VD; Levin CE
Reprod Health Matters; 2008 Nov; 16(32):104-12. PubMed ID: 19027628
[TBL] [Abstract][Full Text] [Related]
20. Cervical cancer screening in Mediterranean countries: implications for the future.
Syrjänen K; Di Bonito L; Gonçalves L; Murjal L; Santamaria M; Mahovlic V; Karakitsos P; Onal B; Schmitt FC
Cytopathology; 2010 Dec; 21(6):359-67. PubMed ID: 20718841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
